USA - NASDAQ:ATNF - US68236V3024 - Common Stock
The current stock price of ATNF is 7.04 USD. In the past month the price increased by 274.47%. In the past year, price increased by 291.11%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.49 | 401.96B | ||
| AMGN | AMGEN INC | 13.39 | 157.25B | ||
| GILD | GILEAD SCIENCES INC | 15.23 | 146.27B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.93 | 108.30B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 62.38B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.34 | 69.37B | ||
| ARGX | ARGENX SE - ADR | 90.81 | 51.50B | ||
| INSM | INSMED INC | N/A | 34.94B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.11 | 34.80B | ||
| NTRA | NATERA INC | N/A | 26.02B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.25B | ||
| BIIB | BIOGEN INC | 9.31 | 21.86B |
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
180 LIFE SCIENCES CORP
3000 El Camino Real, Bldg 4, Ste 200
Palo Alto CALIFORNIA 10019 US
CEO: James N. Woody
Employees: 4
Phone: 16505070669
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
The current stock price of ATNF is 7.04 USD. The price decreased by -7.49% in the last trading session.
ATNF does not pay a dividend.
ATNF has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
180 LIFE SCIENCES CORP (ATNF) operates in the Health Care sector and the Biotechnology industry.
180 LIFE SCIENCES CORP (ATNF) has a market capitalization of 42.52M USD. This makes ATNF a Nano Cap stock.
180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.
ChartMill assigns a technical rating of 9 / 10 to ATNF. When comparing the yearly performance of all stocks, ATNF is one of the better performing stocks in the market, outperforming 99.56% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to ATNF. Both the profitability and financial health of ATNF have multiple concerns.
Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -12.78. The EPS increased by 54.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -160.7% | ||
| ROE | -319.99% | ||
| Debt/Equity | 0.12 |